Cargando…
Corrigendum to Serum hepcidin levels in multiple sclerosis
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6987488/ https://www.ncbi.nlm.nih.gov/pubmed/32064118 http://dx.doi.org/10.1177/2055217320904282 |
Ejemplares similares
-
Serum hepcidin levels in multiple sclerosis
por: Bsteh, Gabriel, et al.
Publicado: (2019) -
Corrigendum to miRNAs in Microglia: Important Players in Multiple Sclerosis
Pathology
Publicado: (2022) -
Corrigendum: Brain network correlates of epilepsy occurrence in multiple sclerosis and neuroinflammation
Publicado: (2023) -
Corrigendum to “Rituximab versus mitoxantrone: comparing effectiveness and safety in advanced relapsing multiple sclerosis”
Publicado: (2021) -
CORRIGENDUM to Progressive multifocal leukoencephalopathy outcomes in patients with multiple sclerosis treated with dimethyl fumarate
Publicado: (2023)